ERLI 10MG TAB

ERLI 10MG contains empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to manage type 2 diabetes mellitus. It works by increasing glucose excretion through urine, helping to lower blood sugar levels effectively. This medication is indicated for adults with type 2 diabetes as monotherapy or in combination with other antidiabetic agents. ERLI 10MG may also provide cardiovascular and renal protective benefits in eligible patients. Take one tablet daily, preferably in the morning, with or without food. Follow your healthcare provider's dosage instructions carefully. Regular blood glucose monitoring is recommended during treatment. Common side effects may include genital infections and urinary tract infections. Inform your doctor about any existing medical conditions, allergies, or concurrent medications before use. Store at room temperature away from moisture and direct sunlight. Keep out of reach of children. Consult your healthcare professional if you experience any adverse effects or have questions about this medication.